401 related articles for article (PubMed ID: 22709421)
1. Visual loss in orbitofacial neurofibromatosis type 1.
Oystreck DT; Morales J; Chaudhry I; Alorainy IA; Elkhamary SM; Pasha TM; Bosley TM
Ophthalmology; 2012 Oct; 119(10):2168-73. PubMed ID: 22709421
[TBL] [Abstract][Full Text] [Related]
2. Ocular motility abnormalities in orbitofacial neurofibromatosis type 1.
Oystreck DT; Alorainy IA; Morales J; Chaudhry IA; Elkhamary SM; Bosley TM
J AAPOS; 2014 Aug; 18(4):338-43. PubMed ID: 25173895
[TBL] [Abstract][Full Text] [Related]
3. Long-term visual outcomes in patients with orbitotemporal neurofibromatosis.
Greenwell TH; Anderson PJ; Madge SK; Selva D; David DJ
Clin Exp Ophthalmol; 2014 Apr; 42(3):266-70. PubMed ID: 23926960
[TBL] [Abstract][Full Text] [Related]
4. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
Thiagalingam S; Flaherty M; Billson F; North K
Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
[TBL] [Abstract][Full Text] [Related]
5. Optic radiation involvement in optic pathway gliomas in neurofibromatosis.
Liu GT; Brodsky MC; Phillips PC; Belasco J; Janss A; Golden JC; Bilaniuk LL; Burson GT; Duhaime AC; Sutton LN
Am J Ophthalmol; 2004 Mar; 137(3):407-14. PubMed ID: 15013861
[TBL] [Abstract][Full Text] [Related]
6. Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1.
Wan MJ; Ullrich NJ; Manley PE; Kieran MW; Goumnerova LC; Heidary G
J Neurooncol; 2016 Aug; 129(1):173-8. PubMed ID: 27311725
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and/or optic pathway gliomas.
Avery RA; Bouffet E; Packer RJ; Reginald A
Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1034-8. PubMed ID: 23329671
[TBL] [Abstract][Full Text] [Related]
8. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.
Dalla Via P; Opocher E; Pinello ML; Calderone M; Viscardi E; Clementi M; Battistella PA; Laverda AM; Da Dalt L; Perilongo G
Neuro Oncol; 2007 Oct; 9(4):430-7. PubMed ID: 17704361
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal measures of visual function, tumor volume, and prediction of visual outcomes after treatment of optic pathway gliomas.
Kelly JP; Leary S; Khanna P; Weiss AH
Ophthalmology; 2012 Jun; 119(6):1231-7. PubMed ID: 22364864
[TBL] [Abstract][Full Text] [Related]
10. Glaucoma and globe enlargement associated with neurofibromatosis type 1.
Morales J; Chaudhry IA; Bosley TM
Ophthalmology; 2009 Sep; 116(9):1725-30. PubMed ID: 19729098
[TBL] [Abstract][Full Text] [Related]
11. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1.
Kuenzle C; Weissert M; Roulet E; Bode H; Schefer S; Huisman T; Landau K; Boltshauser E
Neuropediatrics; 1994 Dec; 25(6):295-300. PubMed ID: 7770126
[TBL] [Abstract][Full Text] [Related]
12. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening.
Levin MH; Armstrong GT; Broad JH; Zimmerman R; Bilaniuk LT; Feygin T; Li Y; Liu GT; Fisher MJ
Br J Ophthalmol; 2016 Apr; 100(4):510-4. PubMed ID: 26294105
[TBL] [Abstract][Full Text] [Related]
13. Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials.
Chang BC; Mirabella G; Yagev R; Banh M; Mezer E; Parkin PC; Westall CA; Buncic JR
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2895-902. PubMed ID: 17525226
[TBL] [Abstract][Full Text] [Related]
14. Optic pathway glioma in children: does visual deficit correlate with radiology in focal exophytic lesions?
Aquilina K; Daniels DJ; Spoudeas H; Phipps K; Gan HW; Boop FA
Childs Nerv Syst; 2015 Nov; 31(11):2041-9. PubMed ID: 26277358
[TBL] [Abstract][Full Text] [Related]
15. Ophthalmic findings in Apert's syndrome after craniofacial surgery: twenty-nine years' experience.
Khong JJ; Anderson P; Gray TL; Hammerton M; Selva D; David D
Ophthalmology; 2006 Feb; 113(2):347-52. PubMed ID: 16458095
[TBL] [Abstract][Full Text] [Related]
16. Orbitofacial neurofibromatosis: clinical characteristics and treatment outcome.
Chaudhry IA; Morales J; Shamsi FA; Al-Rashed W; Elzaridi E; Arat YO; Jacquemin C; Oystreck DT; Bosley TM
Eye (Lond); 2012 Apr; 26(4):583-92. PubMed ID: 22193879
[TBL] [Abstract][Full Text] [Related]
17. Neurofibromatosis type 1 and optic pathway glioma. A long-term follow-up.
Lama G; Esposito Salsano M; Grassia C; Calabrese E; Grassia MG; Bismuto R; Melone MA; Russo S; Scuotto A
Minerva Pediatr; 2007 Feb; 59(1):13-21. PubMed ID: 17301720
[TBL] [Abstract][Full Text] [Related]
18. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
[TBL] [Abstract][Full Text] [Related]
19. Optic glioma warranting treatment in children.
Kaufman LM; Doroftei O
Eye (Lond); 2006 Oct; 20(10):1149-64. PubMed ID: 17019413
[TBL] [Abstract][Full Text] [Related]
20. The cupped disc. Who needs neuroimaging?
Greenfield DS; Siatkowski RM; Glaser JS; Schatz NJ; Parrish RK
Ophthalmology; 1998 Oct; 105(10):1866-74. PubMed ID: 9787356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]